Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer

Clinical trial NCT01231802 · UNKNOWN

Trial details

NCT number: NCT01231802
Sponsor: Adherex Technologies, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2011-04-01
Primary completion: 2012-08-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.